Literature DB >> 15322186

The chemoattractants, IL-8 and formyl-methionyl-leucyl-phenylalanine, regulate granulocyte colony-stimulating factor signaling by inducing suppressor of cytokine signaling-1 expression.

Nigel J Stevenson1, Serge Haan, Angela E McClurg, Michael J McGrattan, Marilyn A Armstrong, Peter C Heinrich, James A Johnston.   

Abstract

Suppressors of cytokine signaling (SOCS) are encoded by immediate early genes known to inhibit cytokine responses in a classical feedback loop. SOCS gene expression has been shown to be induced by many cytokines, growth factors, and innate immune stimuli, such as LPS. In this paper, we report that the chemoattractants, IL-8 and fMLP, up-regulate SOCS1 mRNA in human myeloid cells, primary human neutrophils, PBMCs, and dendritic cells. fMLP rapidly up-regulates SOCS1, whereas the induction of SOCS1 upon IL-8 treatment is delayed. IL-8 and fMLP did not signal via Jak/STATs in primary human macrophages, thus implicating the induction of SOCS by other intracellular pathways. As chemoattractant-induced SOCS1 expression in neutrophils may play an important role in regulating the subsequent response to growth promoting cytokines like G-CSF, we investigated the effect of chemoattractant-induced SOCS1 on cytokine signal transduction. We show that pretreatment of primary human neutrophils with fMLP or IL-8 blocks G-CSF-mediated STAT3 activation. This study provides evidence for cross-talk between chemoattractant and cytokine signal transduction pathways involving SOCS proteins, suggesting that these chemotactic factors may desensitize neutrophils to G-CSF via rapid induction of SOCS1 expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322186     DOI: 10.4049/jimmunol.173.5.3243

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  A MyD88-JAK1-STAT1 complex directly induces SOCS-1 expression in macrophages infected with Group A Streptococcus.

Authors:  Jinghua Wu; Cuiqing Ma; Haixin Wang; Shuhui Wu; Gao Xue; Xinli Shi; Zhang Song; Lin Wei
Journal:  Cell Mol Immunol       Date:  2014-11-17       Impact factor: 11.530

2.  Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells.

Authors:  William A Sands; Hayley D Woolson; Gillian R Milne; Claire Rutherford; Timothy M Palmer
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

3.  Leukotriene B4 amplifies NF-κB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression.

Authors:  Carlos H Serezani; Casey Lewis; Sonia Jancar; Marc Peters-Golden
Journal:  J Clin Invest       Date:  2011-01-04       Impact factor: 14.808

Review 4.  SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?

Authors:  R Mahony; S Ahmed; C Diskin; N J Stevenson
Journal:  Cell Mol Life Sci       Date:  2016-05-02       Impact factor: 9.261

5.  Cell polarity factor Par3 binds SPTLC1 and modulates monocyte serine palmitoyltransferase activity and chemotaxis.

Authors:  Norimasa Tamehiro; Zahedi Mujawar; Suiping Zhou; Debbie Z Zhuang; Thorsten Hornemann; Arnold von Eckardstein; Michael L Fitzgerald
Journal:  J Biol Chem       Date:  2009-07-10       Impact factor: 5.157

6.  Molecular basis of oncostatin M-induced SOCS-3 expression in astrocytes.

Authors:  Brandi J Baker; Hongwei Qin; Etty N Benveniste
Journal:  Glia       Date:  2008-08-15       Impact factor: 7.452

7.  Recent advances in underlying pathologies provide insight into interleukin-8 expression-mediated inflammation and angiogenesis.

Authors:  Basit Saleem Qazi; Kai Tang; Asma Qazi
Journal:  Int J Inflam       Date:  2011-12-22

8.  PDGF-driven proliferation, migration, and IL8 chemokine secretion in human corneal fibroblasts involve JAK2-STAT3 signaling pathway.

Authors:  Neeraj Vij; Ajay Sharma; Mahesh Thakkar; Sunilima Sinha; Rajiv R Mohan
Journal:  Mol Vis       Date:  2008-05-30       Impact factor: 2.367

Review 9.  Novel Psychoactive Substances: The Razor's Edge between Therapeutical Potential and Psychoactive Recreational Misuse.

Authors:  Beatriz Correia; Joana Fernandes; Maria João Botica; Carla Ferreira; Alexandre Quintas
Journal:  Medicines (Basel)       Date:  2022-03-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.